当前位置: X-MOL 学术ACS Biomater. Sci. Eng. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers
ACS Biomaterials Science & Engineering ( IF 5.8 ) Pub Date : 2017-09-15 00:00:00 , DOI: 10.1021/acsbiomaterials.7b00561
Yaoying Wu 1 , Pamela K. Norberg 2 , Elizabeth A. Reap 2 , Kendra L. Congdon 2 , Chelsea N. Fries 1 , Sean H. Kelly 1 , John H. Sampson 2 , Vincent P. Conticello 3 , Joel H. Collier 1
Affiliation  

A supramolecular peptide vaccine system was designed in which epitope-bearing peptides self-assemble into elongated nanofibers composed almost entirely of α-helical structure. The nanofibers were readily internalized by antigen presenting cells and produced robust antibody, CD4+ T-cell, and CD8+ T-cell responses without supplemental adjuvants in mice. Epitopes studied included a cancer B-cell epitope from the epidermal growth factor receptor class III variant (EGFRvIII), the universal CD4+ T-cell epitope PADRE, and the model CD8+ T-cell epitope SIINFEKL, each of which could be incorporated into supramolecular multiepitope nanofibers in a modular fashion.

中文翻译:

基于α-螺旋肽纳米纤维的超分子疫苗平台

设计了一种超分子肽疫苗系统,其中带有抗原决定基的肽自组装成几乎完全由α-螺旋结构组成的细长纳米纤维。纳米纤维易于被抗原呈递细胞内化,并在小鼠中产生强大的抗体,CD4 + T细胞和CD8 + T细胞反应,而无需补充佐剂。研究的抗原决定簇包括来自表皮生长因子受体III类变体(EGFRvIII)的癌症B细胞抗原决定簇,通用CD4 + T细胞抗原决定簇PADRE和模型CD8 + T细胞抗原决定簇SIINFEKL,每种都可以整合到超分子多表位中纳米纤维以模块化的方式。
更新日期:2017-09-15
down
wechat
bug